Seoul, South Korea

Seong-Hoe Park

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Seong-Hoe Park: Innovator in Cancer Therapeutics

Introduction

Seong-Hoe Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research, particularly in the development of diagnostic and therapeutic applications for acute leukemia and lymphoblastic lymphoma. With a total of 6 patents to his name, Park's work is paving the way for advancements in medical treatments.

Latest Patents

One of his latest patents is titled "Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof." This invention focuses on a CD43 epitope expressed on human acute leukemia and lymphoblastic lymphoma cells, which is not present on mature hematopoietic cells, hematopoietic stem cells, or non-hematopoietic cells. The patent outlines its diagnostic and therapeutic applications for these types of cancer.

Another significant patent is "Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof." This invention describes an antibody that binds to human intercellular adhesion molecule-1 (ICAM-1), which can modulate the differentiation status of dendritic cells and prolong graft survival. The patent also includes a pharmaceutical composition comprising the antibody and methods for its use in treating diseases.

Career Highlights

Seong-Hoe Park is currently associated with Dinona Inc., where he continues to innovate in the field of cancer therapeutics. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from acute leukemia and lymphoblastic lymphoma.

Collaborations

Park has collaborated with notable colleagues, including Kyeong-Cheon Jung and Seong-Pyo Park, to further advance research in his field. Their combined expertise contributes to the development of innovative solutions in cancer treatment.

Conclusion

Seong-Hoe Park is a dedicated inventor whose work in cancer research is making a significant impact. His patents reflect a commitment to improving diagnostic and therapeutic strategies for acute leukemia and lymphoblastic lymphoma. Through his efforts, he is contributing to the advancement of medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…